Human serum paraoxonase-1 (hPON1):in vitroinhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium-Reference-Cited by-同舟云学术

Human serum paraoxonase-1 (hPON1):in vitroinhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium

Published:2014-12-18 Issue:4 Volume:30 Page:622-628
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Türkeş Cüneyt,Söyüt Hakan,Beydemir Şükrü

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/14756366.2014.959511

Reference67 articles.

1. Spectrofluorimetric study of the interaction between europium(III) and moxifloxacin in micellar solution and its analytical application

2. Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis

3. Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum

4. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naphthoquinones and anthraquinones: Exploring their impact on acetylcholinesterase enzyme activity;Biotechnology and Applied Biochemistry;2024-05-07

2. Naphthoquinones and Anthraquinones: Exploring Their Impact on Acetylcholinesterase Enzyme Activity;2024

3. Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies;Journal of Biochemical and Molecular Toxicology;2022-06-16

4. Recombinant human carbonic anhydrase VII: Purification, characterization, inhibition, and molecular docking studies;Biotechnology and Applied Biochemistry;2022-06-08

5. Inhibitory Effect of Methotrexate (MTX) Used in Human Cancer Treatment on Paraoxonase-1 (PON1);International Journal of Pharmacology;2022-05-15